Primary intraosseous carcinoma of the head and neck is rare, and lesions isolated to the anterior maxilla are obviously even more rare. Th e diagnosis of intraosseous carcinoma can be diffi cult, and it must be based on strict criteria. We report the case of a 40-year-old man who was referred for defi nitive treatment of a cancerous lesion of the anterior maxilla. Th e patient's mass had initially been thought to be a benign odontogenic cyst. Th e patient was treated with surgery and prosthetic rehabilitation. We describe the clinical presentation, pertinent workup including imaging, and the treatment of this case, and we review the literature.
Introduction
Primary intraosseous carcinoma (PIOC) is defi ned as an odontogenic squamous cell carcinoma (SCC) that (1) develops from residual odontogenic epithelium, (2) has no initial connection with the oral mucosa, and (3) arises within the jaws. 1, 2 PIOCs can be classifi ed as one of six types (table). 1, 2 PIOCs primarily arise within the mandible; those isolated to the anterior maxilla are quite rare. Th ese lesions encompass a variety of histologic types, with various etiologies warranting particular guidelines for diagnosis. No standard treatment has emerged in view of the scarcity of cases. We present a case of PIOC that arose in the anterior maxilla, and we review the literature on this entity.
Case report
A 40-year-old man of Asian Indian descent presented to his primary care physician with a 3-month history of a nonproductive cough and a 1-month history of an asymptomatic swelling over the left gingivolabial sulcus. Computed tomography (CT) demonstrated an ill-defi ned destructive lesion of the maxilla (fi gure 1). Th is lesion was thought to be of odontogenic origin, and the patient was referred to an oral surgeon, who performed a biopsy. Th e fi nal pathology of the specimen was consistent with a well-diff erentiated, keratinizing, invasive SCC.
Th e patient was then referred to our medical center. Laboratory tests and CT of the neck and chest detected no evidence of cervical lymphadenopathy or metastatic disease. Physical examination revealed fullness in the left nasolabial region with mild skin erythema, but no ulceration or signifi cant pain or paresthesias. Intranasally, a mass without mucosal ulceration was noted in the area around the root of the left inferior turbinate. Intraoral examination identifi ed a localized swelling of the left anterior gingiva with loose dentition but, again, no mucosal ulcerations. Th ere were no palpable neck masses. Th e patient's previous pathology was reviewed by our pathologists, who found it to be consistent with SCC.
Th e patient was taken to the operating room for surgical excision of the lesion via a transfacial, sublabial, and intranasal approach. Examination of the nasal passage and the maxillary sinus revealed normal mucosa with no evidence of ulceration. An area of involved cheek skin was removed en bloc with the anterior maxilla from the socket of tooth 6 to the socket of tooth 13. Th e specimen included the left anterior hard palate and teeth 7 through 11 (fi gure 2). Th e facial incision was closed primarily, a skin graft was placed on the posterior aspect of the cheek fl ap, a dacryocystorhinostomy was performed, and the palatal defect was rehabilitated with an obturator. Th e with either ill-defi ned (51.6% of all cases) or well-defi ned (19.4%) margins. 5 In making the diagnosis, one must distinguish PIOC from other lesions, such as metastatic lesions or carcinomas originating in the sinonasal mucosa, oral mucosa, or alveolar tissue with bony destruction. For a defi nitive diagnosis, the tumor must (1) demonstrate histologic evidence of SCC, (2) originate in residual odontogenic epithelium, (3) demonstrate no initial connection to or ulceration of the overlying oral, antral, or nasal mucosa or skin, and (4) be located within the jaws. 1, 2 Given the rarity of this type of tumor and its lack of mucosal changes, a delay in diagnosis is not uncommon.
PIOC occurs much less oft en in the maxilla than in the mandible. In our review of the literature, we found only 9 cases of PIOC in the maxilla. Th ree of these cases were published as individual case reports, 2,6,7 and the other 6 were reported in case series of PIOC tumors. 5, 8 In the literature, most PIOC tumors were found within the posterior mandible, where remnants of dental lamina are believed to persist. 1, 4, 6, 8 PIOC is highly malignant, and it should be treated aggressively. 2, 8 En bloc wide surgical resection with clean margins and neck dissection for clinically apparent lymphadenopathy are the mainstays of treatment. 4 Surgical therapy has been recommended for PIOC because radiation therapy is not as eff ective for cancers that have invaded bone, and PIOCs start in the bone.
Th e need for elective neck dissection and/or adjuvant chemoradiation therapy is controversial. 1, 6, 8, 9 With respect to neck dissection, the reported incidence of lymph node metastasis ranges from 5 to 43%. 8, 10 With regard to adjuvant treatment, Zwetyenga et al found that patients who had been treated with surgery followed by radiotherapy had 2-and 3-year survival rates of 61.3 and 40.9%, respectively, compared with 59.7 and 31.3%, respectively, for patients who had been treated patient's postoperative course was unremarkable.
Final pathology demonstrated a well-diff erentiated SCC invading the facial soft tissue, the inferior and lateral walls of the left nasal cavity, and the left maxillary sinus with negative margins. Th e patient was then evaluated by our radiation oncologist, who recommended adjuvant radiotherapy to the primary site and ipsilateral left neck in view of the tumor's invasion into the facial soft tissues. However, the patient refused additional treatment. At follow-up 1 year postoperatively, he was doing well with his obturator, and he had no evidence of disease.
Discussion
PIOC primarily occurs in the tooth-bearing areas of the jaws. It is speculated that epithelial remnants of odontogenic tissue can give rise to benign or malignant jaw tumors. Th ese cells are believed to originate in the epithelial rests of Malassez within the periodontal ligament, in the enamel epithelium that surrounds the crown of unerupted teeth, or in remnants of dental lamina within the fi brous tissue of the gingiva or bone. 3 Patients with PIOC commonly present with asymptomatic gingival swelling, nonspecifi c dental pain, or ill-fi tting dentures. PIOC is more common in men than women by a ratio of 3 to 1, and its prevalence peaks during the sixth and seventh decades of life. 4 In a review of 39 cases of PIOC, Suei et al reported that 25 of 31 patients (80.6%) demonstrated swelling of the oral mucosa, but only 3 of 36 (8.3%) had ulcer formation. 5 In addition, pain was confi rmed in 25 of 34 patients (73.5%), sensory disturbances in 9 of 15 patients (60.0%), and regional lymph node metastasis in 13 of 33 patients (39.4%). 5 Finally, radiographic images showed that most lesions caused bone resorption diff erently. 8 Th e diff erences in survival were not statistically signifi cant (p = 0.60), but there was a trend toward better survival in the fi rst group of patients. Radiotherapy has been advocated because these tumors mimic behavior patterns similar to those of locally advanced SCCs of the oral mucosa, particularly T4 gum carcinoma, which warrant aggressive initial treatment. Overall 2-year survival rates range from 40 to 60%, and 5-year rates range between 30 and 40%. 4 Additionally, Chen et al in China concluded that postoperative radiotherapy should be given to patients with (1) positive operative margins, (2) tumor involvement of adjacent soft tissues, (3) metastatic neck nodes, and (4) partial excision of the primary tumor. 11 It is important to recognize the variety of lesions in the diff erential diagnosis of radiolucent lesions of the jaws because PIOC lesions are aggressive and require multimodality therapy. Th e diff erential diagnosis includes carcinoma, osteosarcoma, invasive oral mucosal lesions, distant metastasis, and ameloblastoma, as well as a variety of benign lesions such as globulomaxillary cysts, dentigerous cysts, odontogenic keratocysts, and primordial cysts. 12 Th e overall recurrence rate in one study was 56%. 8 Th e prognosis is infl uenced by delays in diagnosis, the presence of cervical lymphadenopathy, and the choice of treatment modality. 4, [8] [9] [10] In a review of the literature, Chaisuparat et al analyzed 134 reported cases of PIOC and found that 82 were PIOC type 1 and 52 were PIOC type 3. 13 Patients with type 1 tumors tended to have a more favorable prognosis.
Our patient had a PIOC type 3a tumor, which had arisen de novo without a preexisting cyst or evidence of mucosal ulceration. He had no evidence of metastatic lymphadenopathy, and his metastatic workup was negative for distant lesions. He was taken for a wide local resection of the lesion and was off ered adjuvant radiation therapy, which he refused. At follow-up, he was doing well with a palatomaxillary prosthesis. 
